Implementing Drug-of-Abuse Testing at the Point of Care: Device Characteristics and Decision Criteria With Selected Emphasis on the Biosite Triage System

Plastic Surgical Nursing

Volumn 4, Issue 3, 2005, Pages 123-127

  Melanson, Stacy E F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

drugs of abuse; point of care; Triage

Indexed keywords

EID: 45849122246     PISSN: 07415206     EISSN: 15501841     Source Type: Journal    
DOI: 10.1097/01.poc.0000179157.39461.50     Document Type: Article

References (16)

1. Watson ID, Bertholf R, Hammett-Stabler C, et al. NACB laboratory guidelines for evidence-based practice for POCT: evidence based point of care testing for drugs and ethanol. In press.
2. George S, Braithwaite RA. Use of on-site testing for drugs of abuse. Clin Chem. 2002;48:1639-1646.
3. Hicks JM, Haeckel R, Price CP, et al. Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta. 2001;303:1-17.
4. Leino A, Saarimies J, Gronholm M, et al. Comparison of eight commercial on-site screening devices for drugs-of-abuse testing. Scand J Clin Lab Invest. 2001;61:325-332.
5. Biosite Inc. Product information Triage Drugs of Abuse Panel. Biosite Inc., San Diego, CA. 11/01.
6. Phillips JE, Bogema S, Fu P, et al. Signify ER drug screen test evaluation: comparison of Triage drug of abuse panel plus tricyclic antidepressants. Clin Chim Acta. 2003;328:31-38.
7. Yang JM, Lewandrowski KB. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT). Clin Chim Acta. 2001;307:27-32.
8. Schwartz JG, Hurd IL, Carnahan JJ. Determination of tricyclic antidepressants for ED analysis. Am J Emerg Med. 1994;12:513-516.
9. Mastrovitch TA, Bithoney WG, DeBari VA, et al. Point-of-care testing for drugs of abuse in an urban emergency department. Ann Clin Lab Sci. 2002;32:383-386.
10. Taylor EH, Pizzo P. Evaluation of the DrugCheck 9 on-site immunoassay test cup according to a standard method validation protocol. J Anal Toxicol. 2004;28:190-197.
11. Poklis A, Poklis JL, Tarnai LD, et al. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine. J Anal Toxicol. 2000;28:485-488.
12. de la Torre R, Domingo-Salvany A, Badia R, et al. Clinical evaluation of the Triage analytical device for drugs-of-abuse testing. Clin Chem. 1996;42:1433-1438.
13. Taylor EH, Oertli EH, Wolfgang JW, et al. Accuracy of five on-site immunoassay drugs-of-abuse testing devices. J Anal Toxicol. 1999;23:119-124.
14. Wu AHB, Wong SS, Johnson KG, et al. Evaluation of the Triage system for emergency drugs-of-abuse testing in urine. J Anal Toxicol. 1993;17:241-245.
15. Tomaszewski C, Runge J, Gibbs M, et al. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity. J Emerg Med. 2005;28:389-394.
16. Bendtsen P, Hultberg J, Carlsson M, et al. Monitoring ethanol exposure in a clinical setting by analysis of blood, breath, saliva and urine. Alcohol Clin Exp Res. 1999;23:1446-1451.